Home
About
Overview
Sharing Data
ORCID
Help
History (6)
beta-Adrenergic Receptor Kinases
Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy.
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios. Biometrics. 2006 Sep; 62(3):777-84.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Bayes Theorem
Biometry
Breast Neoplasms
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Dose-Response Relationship, Drug
Female
Humans
Likelihood Functions
Logistic Models
Models, Statistical
Odds Ratio
Toxicology
authors with profiles
Yuan Ji